August 2, 2024
New Delhi, India
Investors eagerly await the allotment status of Akums Drugs and Pharmaceuticals’ initial public offering (IPO), which is expected to be finalized today. The IPO, which received a strong response, opened for bidding on July 30 and closed on August 1. Here’s everything you need to know about checking your allotment status and the latest grey market premium (GMP).
IPO Allotment Date and Listing:
- Allotment Date: August 2, 2024
- Shares Credited to Demat Accounts: August 5, 2024
- Refunds for Unsuccessful Bidders: August 5, 2024
- Listing Date: August 6, 2024
- Stock Exchanges: BSE and NSE
How to Check Akums Drugs IPO Allotment Status:
Investors can check the allotment status online through the BSE website or the IPO registrar’s web portal, Link Intime India Private Ltd. Follow these steps to check your allotment status:
- Visit the IPO registrar website: Link Intime India Public Issues
- Select Company: Choose ‘Akums Drugs and Pharmaceuticals Limited’ from the dropdown menu.
- Choose Identification Method: Select from PAN, Application No., DP/Client ID, or Account No/IFSC.
- Enter Details: Input the necessary details based on the chosen identification method.
- Submit: Click on the ‘Submit’ button to view your allotment status.
Subscription Status: The IPO received an overwhelming response, with a total subscription of 63.56 times. Here’s a breakdown of the subscription:
- Retail Individual Investors (RIIs): 21.30 times
- Non-Institutional Investors (NIIs): 42.21 times
- Qualified Institutional Buyers (QIBs): 90.09 times
IPO Details:
- Price Band: ₹646 to ₹679 per share
- Total Issue Size: ₹1,856.74 crore
- Fresh Issue: 1 crore equity shares aggregating to ₹680 crore
- Offer for Sale (OFS): 1.73 crore shares aggregating to ₹1,176.74 crore
- Book Running Lead Managers: ICICI Securities, Axis Bank, Citigroup Global Markets India Private Limited, and Ambit Private Limited
- Registrar: Link Intime India Private Ltd
Grey Market Premium (GMP): The GMP for Akums Drugs IPO today stands at ₹141 per share, indicating a trading price of ₹820 in the grey market. This premium is 20.77% above the issue price of ₹679 per share, showcasing strong market sentiment and investor confidence.
Disclaimer:
CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.
